Search

  • HOME
  • Search
Retraction Notice
Coronavirus disease 2019 in a 2-month-old male infant: a case report from Iran
Hosein Heydari, Seyed Kamal Eshagh Hossaini, Ahmad Hormati, Mahboubeh Afifian, Sajjad Ahmadpour
Clin Exp Pediatr. 2022;65(8):417-417.   Published online July 19, 2022
Clinical note
Infection
Coronavirus disease 2019 in a 13-year-old patient with acute lymphoblastic leukemia
Seyed Kamal Eshagh Hossaini, Zahra Movahedi, Ahmad Hormati, Hosein Heydari, Seyed Jalal Eshagh Hosseini, Fatemeh Khodadust, Mahboubeh Afifian, Sajjad Ahmadpour
Clin Exp Pediatr. 2021;64(5):247-250.   Published online March 8, 2021
Question: What should be considered in an immunocompromised child with coronavirus disease 2019 (COVID-19)?
Finding: Due to the importance of appropriately managing COVID-19 in children with cancer, the possibility of a fatal outcome should be considered in immunocompromised patients who receive chemotherapy agents.
Meaning: In all kinds of infections including COVID-19, disuse management and the development of international guidelines for children with cancer is challenging but important.
Coronavirus disease 2019 in a 2-month-old male infant: a case report from Iran
Hosein Heydari, Seyed Kamal Eshagh Hossaini, Ahmad Hormati, Mahboubeh Afifian, Sajjad Ahmadpour
Clin Exp Pediatr. 2020;63(12):499-502.   Published online September 21, 2020
  • PubMed Central
  • PubMed
  • Scopus
  • Directory of Open Access Journals (DOAJ)